fda and glp-1 issued 25 warning letters to telehealth companies for false misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Exploration of the potential association

Bliddal H, Bays H, Czernichow S, Udden Hemmingsson J, Hjelmesaeth J, Hoffmann Morville T, Koroleva A, Skov Neergaard J, Velez Sanchez P, Wharton S, Wizert A, Kristensen LE, Group SS (2024) Once-weekly semaglutide in persons with obesity and knee osteoarthritis

Given the nature of its route of administration, Ozempic may also cause some minor injection site reactions

Diabetes Type Specificity: While semaglutide is effective for type 2 diabetes, it is not suitable for type 1 diabetes management

Rapid body changes and identity disruption Significant weight loss changes more than the number on the scale

Swallow this, measure that, remember to take it at the right timetoo much work

Researchers can use GLP-1 receptor agonists, which have received diabetes treatment approval, to develop arthritis therapies because this approach will shorten both the time needed for drug development and the expenses involved